CAS RN: 936-16-3
2,3-DIHYDRO-1,1-DIOXO-1,2-BENZISOTHIAZOLE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260526
100mg / 250mg / 1g / 5g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 936-16-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
936-16-3 / 2,3-dihydro-1,2-benzothiazole 1,1-dioxide
Standard CAS: 936-16-3
Multi CAS: No
Basic Information
copy
CAS
936-16-3 copy
Multi CAS
No copy
Molecular Formula
C7H7NO2S copy
Molecular Weight
169.200000 copy
Exact Mass
169.019750 copy
InChI
InChI=1S/C7H7NO2S/c9-11(10)7-4-2-1-3-6(7)5-8-11/h1-4,8H,5H2 copy
InChIKey
GVYVHZKTSVDMNT-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.14 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
40.47 copy
TPSA
46.17 copy
LogP / Solubility
WLOGP
0.48 copy
MLOGP
0.42 copy
XLogP3
0.5 copy
Consensus LogP
0.47 copy
Log S (ESOL)
-1.59 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.29 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.16 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.41 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy